does semaglutide help with fatty liver and nafld Efficacy safety of in non-alcoholic disease Therapeutic Mechanisms and Clinical Effects Semaglutide might be a key

Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks

Another randomized clinical trial compared the safety and efficacy of semaglutide with liraglutide (another GLP-1 agonist used for diabetes and weight loss) in people who are overweight or obese

Both medications require titration , meaning people start on the lowest dose and gradually increase over time to minimize side effects

Never use sterile water without preservative

P.JonesM.et al (2010)